Aclaris Therapeutics, Inc. (ACRS)
6.58
+0.27
(+4.28%)
USD |
NASDAQ |
Aug 25, 13:43
Aclaris Therapeutics 1 Year Total Returns (Daily) : 250.6% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 250.6% |
| August 21, 2026 | 266.3% |
| August 20, 2026 | 249.7% |
| August 19, 2026 | 259.8% |
| August 18, 2026 | 240.8% |
| August 17, 2026 | 216.6% |
| August 14, 2026 | 242.0% |
| August 13, 2026 | 244.7% |
| August 12, 2026 | 256.1% |
| August 11, 2026 | 261.0% |
| August 10, 2026 | 262.0% |
| August 07, 2026 | 276.4% |
| August 06, 2026 | 292.9% |
| August 05, 2026 | 310.3% |
| August 04, 2026 | 283.3% |
| August 03, 2026 | 261.4% |
| July 31, 2026 | 239.9% |
| July 30, 2026 | 247.7% |
| July 29, 2026 | 230.3% |
| July 28, 2026 | 217.3% |
| July 27, 2026 | 215.9% |
| July 24, 2026 | 211.3% |
| July 23, 2026 | 226.2% |
| July 22, 2026 | 246.9% |
| July 21, 2026 | 247.0% |
| Date | Value |
|---|---|
| July 20, 2026 | 246.0% |
| July 17, 2026 | 257.2% |
| July 16, 2026 | 239.2% |
| July 15, 2026 | 268.4% |
| July 14, 2026 | 243.7% |
| July 13, 2026 | 250.3% |
| July 10, 2026 | 250.9% |
| July 09, 2026 | 270.8% |
| July 08, 2026 | 280.0% |
| July 07, 2026 | 284.9% |
| July 06, 2026 | 281.2% |
| July 02, 2026 | 283.4% |
| July 01, 2026 | 278.7% |
| June 30, 2026 | 272.5% |
| June 29, 2026 | 241.5% |
| June 26, 2026 | 220.5% |
| June 25, 2026 | 201.2% |
| June 24, 2026 | 215.1% |
| June 23, 2026 | 254.0% |
| June 22, 2026 | 233.8% |
| June 18, 2026 | 216.9% |
| June 17, 2026 | 215.7% |
| June 16, 2026 | 201.4% |
| June 15, 2026 | 196.6% |
| June 12, 2026 | 182.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Corcept Therapeutics, Inc. | 75.23% |
| Nektar Therapeutics | 172.6% |
| Xeris Biopharma Holdings, Inc. | 12.77% |
| Crinetics Pharmaceuticals, Inc. | 174.2% |
| Alumis, Inc. | 375.8% |